ALPINE IMMUNE SCIENCES, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
ALPINE IMMUNE SCIENCES, INC. had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $182.01 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2022-11-14
- 2022-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $182.01M.
- 2022-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $99.54M.
- 2022-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $115.43M.
- 2021-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $120.90M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2022-09-30 | $182.01M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $99.54M 10-Q · filed 2022-11-14 | |
| 2022-03-31 | $115.43M 10-Q · filed 2022-11-14 | |
| 2021-12-31 | $120.90M 10-Q · filed 2022-11-14 | |
| 2021-09-30 | $122.83M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $43.83M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $53.29M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $62.16M 10-Q · filed 2022-11-14 | |
| 2020-09-30 | $67.47M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $16.23M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $24.86M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $29.47M 10-Q · filed 2021-11-10 | |
| 2019-09-30 | $34.83M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $45.42M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $56.58M 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $44.59M 10-Q · filed 2020-11-12 | |
| 2018-09-30 | $54.98M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $66.55M 10-Q · filed 2019-11-14 | |
| 2018-03-31 | $73.88M 10-Q · filed 2019-11-14 | |
| 2017-12-31 | $78.92M 10-K · filed 2020-03-30 | |
| 2017-09-30 | $82.97M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $46.07M 10-Q · filed 2017-07-21 | |
| 2017-03-31 | $49.22M 10-Q · filed 2017-05-02 | |
| 2016-12-31 | -$1.46M 10-K · filed 2020-03-30 | $55.44M 10-K · filed 2017-02-13 |
| 2016-09-30 | $62.10M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $68.69M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $76.36M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | -$352.00K 10-K · filed 2019-03-18 | $83.49M 10-K · filed 2016-03-08 |
| 2015-09-30 | $89.38M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $95.12M 10-Q · filed 2015-08-04 | |
| 2014-12-31 | $0.00 10-K · filed 2018-03-28 | -$15.75M 10-Q · filed 2015-08-04 |
| 2013-12-31 | -$91.29M 10-K · filed 2017-02-13 | |
| 2012-12-31 | -$75.19M 10-K · filed 2016-03-08 |